Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Laboratorios Salvat develops and manufactures pharmaceutical products. It offers antiseptics, analgesics, antipyretics, and antibiotics. The company was founded in 1955 and is headquartered in Esplugues de Llobregat, Spain.

Pola Chemical Industry, Inc. provides cosmetic products, chemicals doranidazole, and pola cosmetics. The company is headquartered in Shinagawa-Ku, Japan.

Eurodrug Laboratories is a private company headquartered in Hyderabad, India, that manufactures drugs and medicines.

e-Therapeutics Plc, is a drug discovery and development company, which engages in the provision of evaluation services to investors and pharmaceutical companies. The company focuses on the therapeutic immune-oncology, addressing drug resistance in targeted cancer therapies and antivirals. It offers the following variety of preclinical stage assets: ETS2300, telomerase inhibition in anti-cancer; ETS3100, small molecule anti-TNFa; ETS2400, Hedgehog pathway inhibition; and ETS5200, broad spectrum antivirals together with two immuno-oncology checkpoint projects. The company was founded by Malcolm Philip Young on October 15, 2001 and is headquartered in London, the United Kingdom.

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Jaleva Pharmaceuticals, LLC, a specialty pharmaceutical company, engages in the research and development of dermal drug delivery system that promotes transmucosal and topical delivery of medications for central nervous system markets. Its products include Mast-R-Prep, a chlorhexidine-based surgical skin prep product; and Stayzon, an antibiotic surgical adhesive. The company’s formulations are designed to provide delivery of alprazolam for anxiety; ondansetron for nausea; sumitriptan for migraines; fentanyl for pain; and nicotine as an aid to smoking cessation. Jaleva Pharmaceuticals, LLC was founded in 1999 and is based in San Diego, California.

Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan.

Laboratoires Innothera manufactures and sells medical devices. Its brands include ATRICAN, BACTOX, DERMOBACTER, DIOVENOR, FLUDITEC, and IDEOS. The company is headquartered in Arcueil, France.

Beizhen Shanqing Pharmaceutical Co., Ltd., established on 1998-01-07, Line of business includes ointments,Manufacturing of chemical raw materials(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Harbin Tianmei Pharmaceutical Co., Ltd., established on 2021-10-11, Business scope includes licensed projects:pharmaceutical production;Disinfectant production(Free of Hazardous Chemicals);Production of hygiene products and single-use medical products;Production of Class II Medical Devices;Production of Class III Medical Devices;Production of protective equipment for medical personnel(Class II medical device);Pharmaceutical commissioned production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines);Cosmetic production;Production of food detergents;pharmaceutical production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines).General project:Production of protective equipment for medical personnel(Ι class medical device);Pharmaceutical commissioned production;Production of Class I Medical Devices;Production of Chinese herbal extracts;Manufacturing of medical packaging materials;Manufacturing of daily chemical products.

Nanjing Zeheng Pharmaceutical Technology Development Co., Ltd., established on 2009-10-15, Business scope includes pharmaceuticals,Health products,Daily chemical products,food research,to develop,Technical consulting and technology transfer;Chemical Products(Does not contain hazardous chemicals),laboratory apparatus,laboratory consumables,Sales of daily necessities.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug retail;Drug import and export;Import and export;Technology Import and Export;Drug internet information service;Health food production;Health food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:market survey(Does not include foreign investigations);Conference and Exhibition Services;Information Consulting Service(Not including licensing information consulting services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

HEXAL is the German generic manufacturer and belongs to the worldwide Sandoz Group with its headquarters in Holzkirchen, Bavaria. HEXAL brings biosimilars to the German market. Biosimilars are high-differentiated products, based on very complex biological molecules. Biologics, or biopharmaceuticals, are medicines produced from living organisms using biotechnology techniques. Many biologics are recombinant proteins and are manufactured using „recombinant DNA“ technology, a process that involves inserting a specific gene into a host cell to produce a particular protein. These complex state-of-the-art molecules represent a distinct regulatory class of medicine compared to traditional, chemically synthesized medicines. In Germany HEXAL employs more then 4.000 people at six sites. The company was founded in 1986 and merged with Sandoz in 2006.

Disha Pharmaceutical Group Co., Ltd., established on 1997-04-30, Business range includes tablet,Granules,hard capsule(cephalosporins),Production and sales of small-volume injections of the company's products(The validity period is subject to the license);Chinese Herbal Medicine(Contains direct oral tablets,Processing range:Purification,cut,Fried,Broiled,steamed,cook,stew,Forging,charcoal,control)production and sales of(The validity period is subject to the license);Production and sales of health food(The scope and validity period of the license shall be subject to the Food Hygiene License);the first sort,Production and sales of Class II medical devices;the first sort,Class II medical device business;food production;food sales;Production of food additives,Sales;Import and export of goods and technologies within the filing scope;Research and development of marine biological products,Production,Sales,technology development,Technology transfer and technical consulting services;Indoor and outdoor decoration engineering construction;Inspection and testing services for drug structure confirmation;disinfection products(Free of Hazardous Chemicals),Production and sales of labor insurance products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Morinaga Milk Industry Co., Ltd. engages in the production and distribution of dairy products. Its operations are carried out through the following segments: Food Products and Others. The Food Products segment engages in the production and sale of milk, dairy-based beverages, yogurt, desserts, condensed milk, powdered milk, butter, cheese, ice cream, non-dairy beverages (juice, tea, coffee), and clinical liquid diets. The Others segment provides the real estate leasing services. It also engages in the manufacture and sale of animal feeds; design and construction of plant equipment. The company was founded on September 1, 1917 and is headquartered in Tokyo, Japan.